These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12180313)

  • 1. [Natural history of hepatitis C virus infection].
    de Lédinghen V
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B9-22. PubMed ID: 12180313
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natural history of HCV infection].
    Trinchet JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B144-53. PubMed ID: 12180282
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis C in France].
    Dhumeaux D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B133-7. PubMed ID: 12180280
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis delta virus (HDV) infection and hepatocellular carcinoma (HCC).
    Oliveri F; Brunetto MR; Baldi M; Piantino P; Ponzetto A; Forzani B; Smedile A; Verme G; Bonino F
    Prog Clin Biol Res; 1991; 364():217-22. PubMed ID: 1850527
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.
    Cantarini MC; Trevisani F; Morselli-Labate AM; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
    Am J Gastroenterol; 2006 Jan; 101(1):91-8. PubMed ID: 16405539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: pathogenetic implications of the hepatitis delta virus.
    Oliveri F; Colombatto P; Derenzini M; Trere D; Papotti M; David E; Negro F; Bellati G; Ideo G; D'Aquino M
    Prog Clin Biol Res; 1993; 382():165-70. PubMed ID: 8389050
    [No Abstract]   [Full Text] [Related]  

  • 13. [Natural history of chronic viral hepatitis].
    Benhamou JP
    Pathol Biol (Paris); 1992 Nov; 39(9):893. PubMed ID: 1311439
    [No Abstract]   [Full Text] [Related]  

  • 14. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
    Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
    J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections.
    Kobayashi M; Ikeda K; Hosaka T; Sezaki H; Someya T; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Miyakawa Y; Kumada H
    J Med Virol; 2006 Apr; 78(4):459-65. PubMed ID: 16482557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: chronic hepatitis C--natural history and cofactors.
    Alberti A; Vario A; Ferrari A; Pistis R
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():74-8. PubMed ID: 16225479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hepatitis C: advances and consensus].
    Lerebours E; Marcellin P; Dhumeaux D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B5-6. PubMed ID: 12180308
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of hepatitis C viral infection.
    Muir AJ
    Semin Gastrointest Dis; 2000 Apr; 11(2):54-61. PubMed ID: 10803630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiological factor of hepatocellular carcinoma in Italy.
    Stroffolini T
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):1-5. PubMed ID: 15756142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.